Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Morning Bell 13 March

Grady Wulff
March 13, 2023

Weekly Wrap 10 March

Grady Wulff
March 10, 2023

Morning Bell 10 March

Grady Wulff
March 10, 2023

Morning Bell 9 March

Grady Wulff
March 9, 2023

Morning Bell 8 March

Grady Wulff
March 8, 2023

Morning Bell 7 February

Sophia Mavridis
March 7, 2023

Morning Bell 6 March

Grady Wulff
March 6, 2023

Weekly Wrap 3 March

Grady Wulff
March 3, 2023

Morning Bell 3 March

Sophia Mavridis
March 3, 2023

Morning Bell 2 March

Grady Wulff
March 2, 2023

Morning Bell 1 March

Grady Wulff
March 1, 2023